1. Home
  2. LASE vs GALT Comparison

LASE vs GALT Comparison

Compare LASE & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laser Photonics Corporation

LASE

Laser Photonics Corporation

HOLD

Current Price

$0.80

Market Cap

55.3M

Sector

Industrials

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

BUY

Current Price

$3.74

Market Cap

297.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
LASE
GALT
Founded
2019
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.3M
297.0M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
LASE
GALT
Price
$0.80
$3.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 5.4M
246.4K
Earning Date
08-14-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 36.84
EPS
★ N/A
N/A
Revenue
★ $721,185.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.38
$2.03
52 Week High
$4.65
$7.13

Technical Indicators

Market Signals
Indicator
LASE
GALT
Relative Strength Index (RSI) 35.49 44.51
Support Level $0.57 $3.56
Resistance Level $0.93 $4.30
Average True Range (ATR) 0.06 0.20
MACD 0.01 -0.03
Stochastic Oscillator 38.63 22.72

Price Performance

Historical Comparison
LASE
GALT

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasive blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, machine manufacturing, nuclear maintenance and decommissioning, and surface coating. Geographically, the company generates almost all of its revenue from the domestic market.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: